Pearl River Capital’s Intersect ENT, Inc XENT Stock Holding History

Pearl River Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100	Closed	-$3K	–	909
2018 Q4	$3K	Buy	+100	New	+$2.93K	0.01%	778

Other funds holding XENT

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Pearl River Capital's XENT Position: Q1 2019 in Review

Pearl River Capital sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 100 shares — an estimated $3K sold.

Pearl River Capital first reported a position in XENT in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

Pearl River Capital reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
Pearl River Capital sold 100 Intersect ENT, Inc shares in Q1 2019, an estimated $3K.
Pearl River Capital first reported a position in Intersect ENT, Inc in Q4 2018 and held it in 1 quarter.
Pearl River Capital's Intersect ENT, Inc position peaked at $3K in Q4 2018.
136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.